8,11,14-Eicosatrienoic Acid
"8,11,14-Eicosatrienoic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5.
Descriptor ID |
D015126
|
MeSH Number(s) |
D10.251.355.255.207
|
Concept/Terms |
8,11,14-Eicosatrienoic Acid- 8,11,14-Eicosatrienoic Acid
- Dihomo-gamma-Linolenic Acid
- Acid, Dihomo-gamma-Linolenic
- Dihomo gamma Linolenic Acid
- Dihomogammalinolenic Acid
- Acid, Dihomogammalinolenic
- 8,11,14 Eicosatrienoic Acid
- DHLA
Homo-gamma Linolenic Acid- Homo-gamma Linolenic Acid
- Acid, Homo-gamma Linolenic
- Homo gamma Linolenic Acid
- Linolenic Acid, Homo-gamma
|
Below are MeSH descriptors whose meaning is more general than "8,11,14-Eicosatrienoic Acid".
Below are MeSH descriptors whose meaning is more specific than "8,11,14-Eicosatrienoic Acid".
This graph shows the total number of publications written about "8,11,14-Eicosatrienoic Acid" by people in UAMS Profiles by year, and whether "8,11,14-Eicosatrienoic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2025 | 1 | 0 | 1 | 2020 | 1 | 0 | 1 | 2018 | 1 | 0 | 1 | 2017 | 1 | 0 | 1 | 2016 | 1 | 0 | 1 | 2015 | 1 | 1 | 2 | 2014 | 1 | 0 | 1 | 2013 | 2 | 0 | 2 | 2011 | 1 | 0 | 1 | 2010 | 1 | 0 | 1 | 2008 | 1 | 0 | 1 | 2006 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "8,11,14-Eicosatrienoic Acid" by people in Profiles over the past ten years.
-
de Bourg M, Mishra A, Mohammad RS, Morisseau C, Hammock BD, Imig JD, Vik A. Synthetic Epoxyeicosatrienoic Acid Mimics Protect Mesangial Cells from Sorafenib-Induced Cell Death. Molecules. 2025 Mar 24; 30(7).
-
Imig JD, Jankiewicz WK, Khan AH. Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture. Hypertension. 2020 07; 76(1):3-15.
-
Neck?r J, Hsu A, Hye Khan MA, Gross GJ, Nithipatikom K, Cyprov? M, Ben?k D, Hlav?ckov? M, Sot?kov?-Ka?parov? D, Falck JR, Sedmera D, Kol?r F, Imig JD. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1a via downregulation of prolyl hydroxylase 3. Am J Physiol Heart Circ Physiol. 2018 11 01; 315(5):H1148-H1158.
-
Campbell WB, Imig JD, Schmitz JM, Falck JR. Orally Active Epoxyeicosatrienoic Acid Analogs. J Cardiovasc Pharmacol. 2017 Oct; 70(4):211-224.
-
Sporkov? A, Reddy RN, Falck JR, Imig JD, Kopkan L, Sadowski J, Cervenka L. Interlobular Arteries From 2-Kidney, 1-Clip Goldblatt Hypertensive Rats' Exhibit-Impaired Vasodilator Response to Epoxyeicosatrienoic Acids. Am J Med Sci. 2016 05; 351(5):513-9.
-
Al?nov? P, Huskov? Z, Kopkan L, Sporkov? A, J?chov? ?, Neck?r J, Imig JD, Klevstig M, Kol?r F, Rami Reddy N, Falck JR, Sadowski J, Nishiyama A, Kramer HJ, Melenovsk? V, Cervenkov? L, Kujal P, Vernerov? Z, Cervenka L. Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats. Vascul Pharmacol. 2015 Oct; 73:45-56.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|